Offering a long-acting, non-hormonal birth control option, the approval marks a significant milestone in expanding contraceptive choices for individuals seeking hormone-free alternatives. ...
New AI-driven technology accelerates infection detection in peritoneal dialysis patients, enhances air quality monitoring, and optimizes laboratory analysis across industries....
Collaboration brings clinical-grade magnetoencephalography (MEG) technology to consumers, launching first brain health center in London....
New microelectrothermoforming (μETF) method improves neural recording and stimulation, with applications in artificial retinas and brain-computer interfaces....
Six-month study demonstrates 85% symptom reduction and strong safety profile, advancing a minimally invasive solution for urgency urinary incontinence treatment. ...
The initiative enhances medical education by equipping healthcare professionals with advanced Microwave Ablation techniques to improve cancer treatment outcomes worldwide....
The initiative strengthens opioid prevention across Alabama by providing communities with vital education and at-home medication disposal solutions to reduce misuse and accidental overdoses....
The collaboration enhances Esco's IVF instrument portfolio with Allwin's consumables, offering a comprehensive solution for IVF clinicians and embryologists while expanding market presence in India....
Regulatory green light follows IMROZ Phase 3 study results showing significant progression-free survival benefit...
The new 2 mL pre-filled pen option expands individualized treatment choices for hereditary angioedema (HAE) patients, reinforcing Takeda’s commitment to reducing disease burden and improving quality of life....
